Remove Compound Screening Remove Engineer Remove Gene Therapy Remove Regulation
article thumbnail

What to expect from drug discovery and development in 2023

Drug Discovery World

At the height of the pandemic, DCTs were seen as a viable alternative to keeping the engines running on clinical trials when non-critical in-person care was paused. We are seeing the change from traditional biopharmaceuticals to cell and gene therapies. They will allow us to treat a disease with one single dose.